Pinnacle Associates Ltd. Has $324,000 Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Pinnacle Associates Ltd. cut its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 23.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 12,422 shares of the pharmacy operator’s stock after selling 3,742 shares during the period. Pinnacle Associates Ltd.’s holdings in Walgreens Boots Alliance were worth $324,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in WBA. EverSource Wealth Advisors LLC lifted its position in shares of Walgreens Boots Alliance by 308.4% during the third quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 845 shares in the last quarter. FinTrust Capital Advisors LLC lifted its holdings in Walgreens Boots Alliance by 2,314.5% in the third quarter. FinTrust Capital Advisors LLC now owns 1,328 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 1,273 shares during the period. Tyler Stone Wealth Management lifted its holdings in Walgreens Boots Alliance by 1,280.0% in the third quarter. Tyler Stone Wealth Management now owns 1,380 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 1,280 shares during the period. Milestone Investment Advisors LLC acquired a new position in Walgreens Boots Alliance in the first quarter valued at approximately $31,000. Finally, Planned Solutions Inc. acquired a new position in Walgreens Boots Alliance in the fourth quarter valued at approximately $34,000. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

WBA has been the topic of several analyst reports. Leerink Partnrs restated a “market perform” rating on shares of Walgreens Boots Alliance in a report on Monday, February 26th. TD Cowen lowered their target price on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating for the company in a research note on Wednesday. SVB Leerink lowered their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating for the company in a research note on Monday, March 18th. Raymond James reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Tuesday, March 26th. Finally, TheStreet raised shares of Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a research note on Monday, January 8th. Four investment analysts have rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $24.36.

View Our Latest Analysis on WBA

Walgreens Boots Alliance Stock Down 1.2 %

Shares of WBA stock opened at $18.50 on Thursday. The company has a market capitalization of $15.95 billion, a price-to-earnings ratio of -2.64, a P/E/G ratio of 1.20 and a beta of 0.73. Walgreens Boots Alliance, Inc. has a 12-month low of $18.49 and a 12-month high of $36.58. The firm has a fifty day moving average of $21.57 and a 200-day moving average of $22.23. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 0.50.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last released its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, beating analysts’ consensus estimates of $0.82 by $0.38. The business had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The firm’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter last year, the firm earned $1.16 earnings per share. As a group, equities research analysts predict that Walgreens Boots Alliance, Inc. will post 3.24 earnings per share for the current fiscal year.

Insider Activity at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, CEO Timothy C. Wentworth bought 10,000 shares of the firm’s stock in a transaction that occurred on Friday, January 5th. The stock was acquired at an average price of $24.22 per share, with a total value of $242,200.00. Following the completion of the transaction, the chief executive officer now owns 585,122 shares in the company, valued at $14,171,654.84. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CEO Timothy C. Wentworth purchased 10,000 shares of the business’s stock in a transaction on Friday, January 5th. The stock was purchased at an average price of $24.22 per share, for a total transaction of $242,200.00. Following the completion of the purchase, the chief executive officer now directly owns 585,122 shares in the company, valued at approximately $14,171,654.84. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Valerie B. Jarrett purchased 4,456 shares of the business’s stock in a transaction on Monday, January 29th. The stock was purchased at an average price of $22.44 per share, with a total value of $99,992.64. Following the purchase, the director now owns 4,456 shares of the company’s stock, valued at $99,992.64. The disclosure for this purchase can be found here. Over the last 90 days, insiders acquired 20,456 shares of company stock valued at $458,473. Corporate insiders own 17.40% of the company’s stock.

About Walgreens Boots Alliance

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Recommended Stories

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.